It is very interesting how they think a letter will have any gravitas when considering the long term survival rate
But as we know Incyte may not be that in-sight-ful
LOL
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L, page-385
-
- There are more pages in this discussion • 623 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
96.5¢ |
Change
-0.005(0.52%) |
Mkt cap ! $1.087B | |||
| Open | High | Low | Value | Volume |
| 98.0¢ | 98.5¢ | 95.0¢ | $2.364M | 2.450M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 36 | 78943 | 96.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 96.5¢ | 107253 | 23 |
View Market Depth
| Last trade - 15.56pm 13/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |